Method for treating ischemic conditions

Claim 1

A method for treating an ischemic condition in a patient having an ischemic condition, which method consists essentially of: (a) administering orally from a pharmaceutical dosage form a vasodilator having a group selected from the group consisting of ONO and ONO 2 for the management of an ischemic condition; (b) admininstering transdermally from a medical bandage, a vasodilator having a group selected from the group consisting of ONO and ONO 2 for the management of an ischemic condition, the medical bandage consisting essentially of: (1) a backing member that is substantially impermeable to the passage of a vasodilator; (2) a reservoir in contact with the backing member, the reservoir consisting essentially of a gel of silicon fluid and silicone dioxide and a vasodilator dispersed throughout the gel; (3) a polymeric membrane positioned opposite the backing member and in contact with the reservoir, the membrane formed of a vasodilator release rate controlling material permeable to the passage of the vasodilator, and having its edges in contact with the edges of the backing member in fluid tight arrangement; and, (c) wherein, the vasodilator is administered internally and transdermally in a therapeutically effective amount to the patient for treating the ischemic condition.

Claim 2

A method for treating an ischemic condition in a patient having an ischemic condition, which method consists essentially of: (a) administering orally from a pharmaceutical dosage form a vasodilator having a group selected from the group consisting of ONO and ONO 2 for the management of an ischemic condition; (b) admininstering transdermally from a medical bandage, a vasodilator having a group selected from the group consisting of ONO and ONO 2 for the management of an ischemic condition, the medical bandage consisting essentially of: (1) a backing member that is substantially impermeable to the passage of a vasodilator; (2) a reservoir in contact with the backing member, the reservoir consisting essentially of a gel of silicon fluid and silicone dioxide and a vasodilator dispersed throughout the gel; (3) a polymeric membrane positioned opposite the backing member and in contact with the reservoir, the membrane formed of a vasodilator release rate controlling material permeable to the passage of the vasodilator, and having its edges in contact with the edges of the backing member in fluid tight arrangement; and, (c) wherein, the vasodilator is administered internally and transdermally in a therapeutically effective amount to the patient for treating the ischemic condition.